Diaspanoside B



Compound IDCDAMM02650
Common nameDiaspanoside B
IUPAC name3,6,9-trimethylidene-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one
Molecular formulaC21H28O8

Experimental data

Retention time8.01
Adduct[M+H]+
Actual mz409.189
Theoretical mz409.185
Error9.59
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.434

Identifiers and class information

Inchi keyNFPFDUCKBQMYPB-DWQSONATNA-N
SmilesO=C1OC2C(C1=C)CC(OC3OC(CO)C(O)C(O)C3O)C(=C)C4CCC(=C)C24
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)408.447
Computed dipole moment(dipole)11.339
Total solvent accessible surface area (SASA)639.704
Hydrophobic component of SASA (FOSA)352.205
Hydrophilic component of SASA (FISA)212.819
Pie component of the SASA (PISA)74.679
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1210.09
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)13.2
Free energy of solvation of dipole (dip^2/V)0.106249
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0412691
Globularity descriptor (glob)0.858481
Predicted polarizability in cubic angstroms (QPpolrz)37.85
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.407
Predicted octanol/gas partition coefficient (QPlogPoct)26.983
Predicted water/gas partition coefficient (QPlogPw)20.31
Predicted octanol/water partition coefficient (QPlogPo/w)0.007
Predicted aqueous solubility (QPlogS)-2.645
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.503
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.178
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)95.002
Predicted brain/blood partition coefficient (QPlogBB)-1.844
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)38.851
Predicted skin permeability, log Kp (QPlogKp)-4.411
PM3 calculated ionization potential (IP(ev))9.876
PM3 calculated electron affinity (EA(eV))0.101
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)-0.689
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)62.384
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)136.202
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9BZP6CHIAAcidic mammalian chitinase (by homology)T51597SEA
P32320CDACytidine deaminase (by homology)T79027SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P17931LGALS3Galectin-3T72038SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T79027DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P32320CDA
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6

Copyright © 2025